Skip to main content Accessibility help
×
Hostname: page-component-7479d7b7d-fwgfc Total loading time: 0 Render date: 2024-07-12T21:00:27.214Z Has data issue: false hasContentIssue false

29 - Clonidine

Published online by Cambridge University Press:  06 October 2020

Stephen D. Silberstein
Affiliation:
Thomas Jefferson University, Philadelphia
Michael J. Marmura
Affiliation:
Thomas Jefferson University, Philadelphia
Hsiangkuo Yuan
Affiliation:
Thomas Jefferson University, Philadelphia
Stephen M. Stahl
Affiliation:
University of California, San Diego
Get access

Summary

THERAPEUTICS

Brands

• Catapres, Dixarit, Clorpres, Duraclon (injection only), Kapvay, Jenloga

Generic?

• Yes

Class

• α2-adrenergic agonist

Commonly Prescribed for

(FDA approved in bold)

Hypertension (immediate release only)

Attention deficit hyperactivity disorder (ADHD) (extended release only)

Severe pain in cancer patients

• Postanesthetic shivering

• Withdrawal (alcohol, opiate, methadone)

• Gilles de la Tourette syndrome (GTS), tics

• Smoking cessation

• Growth delay

• Ulcerative colitis

• Menopausal symptoms such as hot flushes

• Neuropathic pain

• Ascites

• Hyperhidrosis

• Anesthesia premedication

• Restless legs syndrome (RLS)

How the Drug Works

• α2 agonist with similar potency at 2A/2B/2C receptors. These adrenergic receptors are distributed throughout the CNS, with α2A and α2C being more in the CNS and α2B more in the periphery (e.g., heart, lung, kidney, liver). Stimulating these presynaptic receptors (α2A, α2C) inhibits norepinephrine release, decreases sympathetic tone, and reduces blood pressure and heart rate. Sedation and analgesia is mediated by centrally located α2A-receptors, while peripheral α2B-receptors mediate vascular constriction. May also reduce plasma renin activity and catecholamine excretion. Additional antihypertensive effect may come from imidazoline I1 receptor agonism

How Long Until It Works

• Hypertension, withdrawal: less than 2 hours

• GTS: weeks to months

• RLS: days

If It Works

• In neurological conditions such as tics, continue to assess effect of the medication and whether it is still needed

If It Doesn't Work

• GTS/tics: neuroleptics are often effective, but their use should be reserved for patients with significant social isolation or embarrassment

• RLS: generally used as an adjunctive agent. Dopamine agonists are more effective

Best Augmenting Combos for Partial Response or Treatment-Resistance

• In hypertension, combine with treatments less likely to affect heart rate or cause orthostasis (ACE inhibitors, diuretics)

• Tics and GTS symptoms may change over time. Many patients improve with age. Behavioral and psychological therapies are useful, and education and reassurance are all that is needed in mild cases

• Identify and treat comorbid conditions such as ADHD or obsessive-compulsive disorder

Type
Chapter
Information
Essential Neuropharmacology
The Prescriber's Guide
, pp. 106 - 109
Publisher: Cambridge University Press
Print publication year: 2015

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

  • Clonidine
  • Stephen D. Silberstein, Thomas Jefferson University, Philadelphia, Michael J. Marmura, Thomas Jefferson University, Philadelphia, Hsiangkuo Yuan, Thomas Jefferson University, Philadelphia
  • Edited in consultation with Stephen M. Stahl, University of California, San Diego
  • Book: Essential Neuropharmacology
  • Online publication: 06 October 2020
  • Chapter DOI: https://doi.org/10.1017/9781316161753.030
Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

  • Clonidine
  • Stephen D. Silberstein, Thomas Jefferson University, Philadelphia, Michael J. Marmura, Thomas Jefferson University, Philadelphia, Hsiangkuo Yuan, Thomas Jefferson University, Philadelphia
  • Edited in consultation with Stephen M. Stahl, University of California, San Diego
  • Book: Essential Neuropharmacology
  • Online publication: 06 October 2020
  • Chapter DOI: https://doi.org/10.1017/9781316161753.030
Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

  • Clonidine
  • Stephen D. Silberstein, Thomas Jefferson University, Philadelphia, Michael J. Marmura, Thomas Jefferson University, Philadelphia, Hsiangkuo Yuan, Thomas Jefferson University, Philadelphia
  • Edited in consultation with Stephen M. Stahl, University of California, San Diego
  • Book: Essential Neuropharmacology
  • Online publication: 06 October 2020
  • Chapter DOI: https://doi.org/10.1017/9781316161753.030
Available formats
×